Latest Breaking News On - Johns hopkins multiple sclerosis center - Page 1 : comparemela.com

Tee up with Johns Hopkins for MS fundraiser to aid research, awareness | Multiple Sclerosis News Today

Form 424B1 MIRA PHARMACEUTICALS,

Biopharma Company Working On Synthetic THC Drug To Treat Anxiety Launches NASDAQ IPO - Mira Pharmaceuticals (NASDAQ:MIRA)

Pre-clinical-stage biopharma company, MIRA Pharmaceuticals (NASDAQ: MIRA) launched its initial public offering Thursday and is trading $6.72 per share at the time of reporting.

#ACTRIMS2021 - MS Progresses Faster Among Socioeconomically Disadvantaged

Click here to subscribe to the Multiple Sclerosis News Today Newsletter! 5 (4) Editor’s note: The Multiple Sclerosis News Today news team is providing in-depth and unparalleled coverage of the virtual ACTRIMS Forum 2021, Feb. 25-27. Go here to see all the latest stories from the conference. People with multiple sclerosis (MS) who are less socioeconomically advantaged tend to have faster rates of nervous system damage, new research suggests. The findings were presented today at the virtual Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2021, in the presentation “Socioeconomic Disparity Correlates with Faster GCIPL Atrophy in MS Patients,” given by Eleni Vasileiou, MD. Vasileiou is a postdoctoral researcher at Johns Hopkins University School of Medicine, Baltimore, Maryland.